---
title: "Propanc Biopharma, Inc. (PPCB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PPCB.US.md"
symbol: "PPCB.US"
name: "Propanc Biopharma, Inc."
industry: "Biotechnology"
---

# Propanc Biopharma, Inc. (PPCB.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.propanc.com](https://www.propanc.com) |

## Company Profile

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.04 | 81/606 | - | - | - |
| PB | 0.28 | 15/606 | 2.73 | 1.40 | 0.50 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/PPCB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PPCB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PPCB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.